دورية أكاديمية
أعرض في EDS

Targeting long noncoding RNAs in neuroblastoma: Progress and prospects.

التفاصيل البيبلوغرافية
العنوان: Targeting long noncoding RNAs in neuroblastoma: Progress and prospects.
المؤلفون: Ataei A; School of Medicine, Bam University of Medical Sciences, Bam, Iran., Tahsili M; Payam Nour University of Taft, Yazd, Iran., Hayadokht G; School of Medicine, Guilan University of Medical Sciences, Rasht, Iran., Daneshvar M; Tehran University of Medical Sciences, Tehran, Iran., Mohammadi Nour S; School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran., Soofi A; Department of Physical Chemistry, School of Chemistry, College of Sciences, University of Tehran, Tehran, Iran., Masoudi A; Department of Laboratory Sciences, Faculty of Alied Medical Sciences, Qom University of Medical Sciences, Qom, Iran., Kabiri M; Faculty of Medicine, Islamic Azad University of Medical Sciences, Tehran, Iran., Natami M; Department of Urology, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
المصدر: Chemical biology & drug design [Chem Biol Drug Des] 2023 Sep; Vol. 102 (3), pp. 640-652. Date of Electronic Publication: 2023 Jun 08.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-0285 (Electronic) Linking ISSN: 17470277 NLM ISO Abbreviation: Chem Biol Drug Des Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford : Wiley-Blackwell, 2006-
مواضيع طبية MeSH: RNA, Long Noncoding*/genetics , Neuroblastoma*, Child ; Humans ; Child, Preschool ; Prognosis ; Gene Expression Regulation, Neoplastic ; Biomarkers, Tumor/genetics
مستخلص: Neuroblastoma (NB) is the third most prevalent tumor that mostly influences infants and young children. Although different treatments have been developed for the treatment of NB, high-risk patients have been reported to have low survival rates. Currently, long noncoding RNAs (lncRNAs) have shown an attractive potential in cancer research and a party of investigations have been performed to understand mechanisms underlying tumor development through lncRNA dysregulation. Researchers have just newly initiated to exhibit the involvement of lncRNAs in NB pathogenesis. In this review article, we tried to clarify the point we stand with respect to the involvement of lncRNAs in NB. Moreover, implications for the pathologic roles of lncRNAs in the development of NB have been discussed. It seems that some of these lncRNAs have promising potential to be applied as biomarkers for NB prognosis and treatment.
(© 2023 John Wiley & Sons Ltd.)
References: Abel, F., Dalevi, D., Nethander, M., Jörnsten, R., de Preter, K., Vermeulen, J., Stallings, R., Kogner, P., Maris, J., & Nilsson, S. (2011). A 6-gene signature identifies four molecular subgroups of neuroblastoma. Cancer Cell International, 11(1), 9.
Arita, T., Ichikawa, D., Konishi, H., Komatsu, S., Shiozaki, A., Shoda, K., Kawaguchi, T., Hirajima, S., Nagata, H., Kubota, T., Fujiwara, H., Okamoto, K., & Otsuji, E. (2013). Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Research, 33(8), 3185-3193.
Asgharzadeh, S., Pique-Regi, R., Sposto, R., Wang, H., Yang, Y., Shimada, H., Matthay, K., Buckley, J., Ortega, A., & Seeger, R. C. (2006). Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. Journal of the National Cancer Institute, 98(17), 1193-1203.
Asgharzadeh, S., Salo, J. A., Ji, L., Oberthuer, A., Fischer, M., Berthold, F., Hadjidaniel, M., Liu, C. W. Y., Metelitsa, L. S., Pique-Regi, R., Wakamatsu, P., Villablanca, J. G., Kreissman, S. G., Matthay, K. K., Shimada, H., London, W. B., Sposto, R., & Seeger, R. C. (2012). Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. Journal of Clinical Oncology, 30(28), 3525-3532.
Atmadibrata, B., Liu, P. Y., Sokolowski, N., Zhang, L., Wong, M., Tee, A. E., Marshall, G. M., & Liu, T. (2014). The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc. PLoS One, 9(2), e88112.
Bagatell, R., Beck-Popovic, M., London, W. B., Zhang, Y., Pearson, A. D., Matthay, K. K., Monclair, T., Ambros, P. F., Cohn, S. L., & International Neuroblastoma Risk Group. (2009). Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: A report from the international Neuroblastoma risk group database. Journal of Clinical Oncology, 27(3), 365-370.
Barnhill, L. M., Williams, R. T., Cohen, O., Kim, Y., Batova, A., Mielke, J. A., Messer, K., Pu, M., Bao, L., Yu, A. L., & Diccianni, M. B. (2014). High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Research, 74(14), 3753-3763.
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., & Haussler, D. (2004). Ultraconserved elements in the human genome. Science, 304(5675), 1321-1325.
Bordow, S. B., Norris, M. D., Haber, P. S., Marshall, G. M., & Haber, M. (1998). Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. Journal of Clinical Oncology, 16(10), 3286-3294.
Brodeur, G. M. (2003). Neuroblastoma: Biological insights into a clinical enigma. Nature Reviews Cancer, 3(3), 203-216.
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984). Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224(4653), 1121-1124.
Bussemakers, M. J., van Bokhoven, A., Verhaegh, G. W., Smit, F. P., Karthaus, H. F., Schalken, J. A., Debruyne, F. M., Ru, N., & Isaacs, W. B. (1999). Dd3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Research, 59(23), 5975-5979.
Cabili, M. N., Trapnell, C., Goff, L., Koziol, M., Tazon-Vega, B., Regev, A., & Rinn, J. L. (2011). Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & Development, 25(18), 1915-1927.
Cai, B., Wu, Z., Liao, K., & Zhang, S. (2014). Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: A meta-analysis. Tumor Biology, 35(9), 8445-8450.
Candeias, M. M. (2011). The can and can't dos of p53 RNA. Biochimie, 93(11), 1962-1965.
Carén, H., Abel, F., Kogner, P., & Martinsson, T. (2008). High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours. Biochemical Journal, 416(2), 153-159.
Carén, H., Kryh, H., Nethander, M., Sjöberg, R. M., Träger, C., Nilsson, S., Abrahamsson, J., Kogner, P., & Martinsson, T. (2010). High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proceedings of the National Academy of Sciences, 107(9), 4323-4328.
Caron, H. (1995). Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Medical and Pediatric Oncology, 24(4), 215-221.
Castelnuovo, M., Massone, S., Tasso, R., Fiorino, G., Gatti, M., Robello, M., Gatta, E., Berger, A., Strub, K., Florio, T., Dieci, G., Cancedda, R., & Pagano, A. (2010). An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. The FASEB Journal, 24(10), 4033-4046.
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., Nakagawara, A., Hayashi, Y., Mano, H., & Ogawa, S. (2008). Oncogenic mutations of ALK kinase in neuroblastoma. Nature, 455(7215), 971-974.
Cheung, N.-K. V., & Dyer, M. A. (2013). Neuroblastoma: Developmental biology, cancer genomics and immunotherapy. Nature Reviews Cancer, 13(6), 397-411.
Cohn, S. L., Pearson, A. D., London, W. B., Monclair, T., Ambros, P. F., Brodeur, G. M., Faldum, A., Hero, B., Iehara, T., Machin, D., Mosseri, V., Simon, T., Garaventa, A., Castel, V., Matthay, K. K., & INRG Task Force. (2009). The international Neuroblastoma risk group (INRG) classification system: An INRG task force report. Journal of Clinical Oncology, 27(2), 289-297.
Consortium, E. P. (2012). An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57-74.
Cooper, C., Vincett, D., Yan, Y., Hamedani, M. K., Myal, Y., & Leygue, E. (2011). Steroid receptor RNA activator bi-faceted genetic system: Heads or tails? Biochimie, 93(11), 1973-1980.
De Preter, K., Mestdagh, P., Vermeulen, J., Zeka, F., Naranjo, A., Bray, I., Castel, V., Chen, C., Drozynska, E., Eggert, A., Hogarty, M. D., Izycka-Swieszewska, E., London, W. B., Noguera, R., Piqueras, M., Bryan, K., Schowe, B., van Sluis, P., Molenaar, J. J., … Vandesompele, J. (2011). miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples. Clinical Cancer Research, 17(24), 7684-7692.
De Preter, K., Vermeulen, J., Brors, B., Delattre, O., Eggert, A., Fischer, M., Janoueix-Lerosey, I., Lavarino, C., Maris, J. M., Mora, J., Nakagawara, A., Oberthuer, A., Ohira, M., Schleiermacher, G., Schramm, A., Schulte, J. H., Wang, Q., Westermann, F., Speleman, F., & Vandesompele, J. (2010). Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature. Clinical Cancer Research, 16(5), 1532-1541.
Derrien, T., Johnson, R., Bussotti, G., Tanzer, A., Djebali, S., Tilgner, H., Guernec, G., Martin, D., Merkel, A., Knowles, D. G., Lagarde, J., Veeravalli, L., Ruan, X., Ruan, Y., Lassmann, T., Carninci, P., Brown, J. B., Lipovich, L., Gonzalez, J. M., … Guigó, R. (2012). The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Research, 22(9), 1775-1789.
Encinas, M., Iglesias, M., Llecha, N., & Comella, J. X. (1999). Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. Journal of Neurochemistry, 73(4), 1409-1421.
Fardin, P., Barla, A., Mosci, S., Rosasco, L., Verri, A., Versteeg, R., Caron, H. N., Molenaar, J. J., Øra, I., Eva, A., Puppo, M., & Varesio, L. (2010). A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Molecular Cancer, 9(1), 185.
Farrar, D., Rai, S., Chernukhin, I., Jagodic, M., Ito, Y., Yammine, S., Ohlsson, R., Murrell, A., & Klenova, E. (2010). Mutational analysis of the poly (ADP-ribosyl) ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly (ADP-ribosyl) ation. Molecular and Cellular Biology, 30(5), 1199-1216.
Feng, W., Li, L., Xu, X., Jiao, Y., & du, W. (2017). Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion. Archives of Medical Science, 13(6), 1315-1321.
Formicola, D., Petrosino, G., Lasorsa, V. A., Pignataro, P., Cimmino, F., Vetrella, S., Longo, L., Tonini, G. P., Oberthuer, A., Iolascon, A., Fischer, M., & Capasso, M. (2016). An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma. Journal of Translational Medicine, 14(1), 142.
George, R. E., Sanda, T., Hanna, M., Fröhling, S., Luther, W., 2nd, Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., Xue, L., Zozulya, S., Gregor, V. E., Webb, T. R., Gray, N. S., Gilliland, D. G., Diller, L., Greulich, H., Morris, S. W., … Look, A. T. (2008). Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature, 455(7215), 975-978.
Guo, C., White, P. S., Weiss, M. J., Hogarty, M. D., Thompson, P. M., Stram, D. O., Gerbing, R., Matthay, K. K., Seeger, R. C., Brodeur, G. M., & Maris, J. M. (1999). Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene, 18(35), 4948-4957.
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M. C., Hung, T., Argani, P., Rinn, J. L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R. B., van de Vijver, M. J., Sukumar, S., & Chang, H. Y. (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464(7291), 1071-1076.
Gutschner, T., & Diederichs, S. (2012). The hallmarks of cancer: A long non-coding RNA point of view. RNA Biology, 9(6), 703-719.
Gutschner, T., Hämmerle, M., Eißmann, M., Hsu, J., Kim, Y., Hung, G., Revenko, A., Arun, G., Stentrup, M., Groß, M., Zörnig, M., MacLeod, A. R., Spector, D. L., & Diederichs, S. (2013). The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Research, 73(3), 1180-1189.
Guttman, M., Amit, I., Garber, M., French, C., Lin, M. F., Feldser, D., Huarte, M., Zuk, O., Carey, B. W., Cassady, J. P., Cabili, M. N., Jaenisch, R., Mikkelsen, T. S., Jacks, T., Hacohen, N., Bernstein, B. E., Kellis, M., Regev, A., Rinn, J. L., & Lander, E. S. (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458(7235), 223-227.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646-674.
Hermanns, P., Reicherter, K., & Lee, B. (2008). RMRP (RNA component of mitochondrial RNA processing endoribonuclease). Atlas of genetics and cytogenetics in oncology and Haematology.
Hessels, D., Klein Gunnewiek, J. M. T., van Oort, I., Karthaus, H. F. M., van Leenders, G. J. L., van Balken, B., Kiemeney, L. A., Witjes, J. A., & Schalken, J. A. (2003). DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. European Urology, 44(1), 8-16.
Hirata, H., Hinoda, Y., Shahryari, V., Deng, G., Nakajima, K., Tabatabai, Z. L., Ishii, N., & Dahiya, R. (2015). Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Research, 75(7), 1322-1331.
Hogarty, M. D., Maris, J. M., White, P. S., Guo, C., & Brodeur, G. M. (2001). Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Medical and Pediatric Oncology, 36(1), 52-55.
Hsu, C.-L., Chang, H. Y., Chang, J. Y., Hsu, W. M., Huang, H. C., & Juan, H. F. (2016). Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data. Oncotarget, 7(24), 36293-36310.
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., Attardi, L. D., Regev, A., Lander, E. S., Jacks, T., & Rinn, J. L. (2010). A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell, 142(3), 409-419.
Iyer, M. K., Niknafs, Y. S., Malik, R., Singhal, U., Sahu, A., Hosono, Y., Barrette, T. R., Prensner, J. R., Evans, J. R., Zhao, S., Poliakov, A., Cao, X., Dhanasekaran, S. M., Wu, Y. M., Robinson, D. R., Beer, D. G., Feng, F. Y., Iyer, H. K., & Chinnaiyan, A. M. (2015). The landscape of long noncoding RNAs in the human transcriptome. Nature Genetics, 47(3), 199-208.
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., Valteau-Couanet, D., Frebourg, T., Michon, J., Lyonnet, S., Amiel, J., & Delattre, O. (2008). Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature, 455(7215), 967-970.
JiP, D., & Wang, W. (2003). mALAT-1, a novel non-coding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22(39), 8031-8041.
Kageyama, Y., Kondo, T., & Hashimoto, Y. (2011). Coding vs non-coding: Translatability of short ORFs found in putative non-coding transcripts. Biochimie, 93(11), 1981-1986.
Kashima, T., Rao, N., David, C. J., & Manley, J. L. (2007). hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing. Human Molecular Genetics, 16(24), 3149-3159.
Katayama, S., Tomaru, Y., Kasukawa, T., Waki, K., Nakanishi, M., Nakamura, M., Nishida, H., Yap, C. C., Suzuki, M., Kawai, J., Suzuki, H., Carninci, P., Hayashizaki, Y., Wells, C., Frith, M., Ravasi, T., Pang, K. C., Hallinan, J., Mattick, J., … Wahlestedt, C. (2005). Antisense transcription in the mammalian transcriptome. Science, 309(5740), 1564-1566.
Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., Regev, A., Lander, E. S., & Rinn, J. L. (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences, 106(28), 11667-11672.
Kim, H. J., Lee, D. W., Yim, G. W., Nam, E. J., Kim, S., Kim, S. W., & Kim, Y. T. (2015). Long non-coding RNA HOTAIR is associated with human cervical cancer progression. International Journal of Oncology, 46(2), 521-530.
Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., & Safe, S. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene, 32(13), 1616-1625.
Kino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010). Noncoding RNA gas5 is a growth arrest-and starvation-associated repressor of the glucocorticoid receptor. Science Signaling, 3(107), ra8.
Kotake, Y., Nakagawa, T., Kitagawa, K., Suzuki, S., Liu, N., Kitagawa, M., & Xiong, Y. (2011). Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15p15 INK4B tumor suppressor gene. Oncogene, 30(16), 1956-1962.
Łastowska, M., Cullinane, C., Variend, S., Cotterill, S., Bown, N., O′Neill, S., Mazzocco, K., Roberts, P., Nicholson, J., Ellershaw, C., Pearson, A. D. J., Jackson, M. S., & for the United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group. (2001). Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. Journal of Clinical Oncology, 19(12), 3080-3090.
Li, D., Wang, X., Mei, H., Fang, E., Ye, L., Song, H., Yang, F., Li, H., Huang, K., Zheng, L., & Tong, Q. (2018). Long noncoding RNA pancEts-1 promotes neuroblastoma progression through hnRNPK-mediated β-catenin stabilization. Cancer Research, 78(5), 1169-1183.
Li, H., An, J., Wu, M., Zheng, Q., Gui, X., Li, T., Pu, H., & Lu, D. (2015). LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2. Oncotarget, 6(29), 27847-27864.
Liu, P. Y., Erriquez, D., Marshall, G. M., Tee, A. E., Polly, P., Wong, M., Liu, B., Bell, J. L., Zhang, X. D., Milazzo, G., Cheung, B. B., Fox, A., Swarbrick, A., Hüttelmaier, S., Kavallaris, M., Perini, G., Mattick, J. S., Dinger, M. E., & Liu, T. (2014). Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. Journal of the National Cancer Institute, 106(7), dju113.
Maris, J., Hogarty, M., & Bagatell, R. (2007). Neuroblastoma. Lancet, 369, 2106-2120.
Maris, J. M. (2010). Recent advances in neuroblastoma. New England Journal of Medicine, 362(23), 2202-2211.
Maris, J. M., Mosse, Y. P., Bradfield, J. P., Hou, C., Monni, S., Scott, R. H., Asgharzadeh, S., Attiyeh, E. F., Diskin, S. J., Laudenslager, M., Winter, C., Cole, K. A., Glessner, J. T., Kim, C., Frackelton, E. C., Casalunovo, T., Eckert, A. W., Capasso, M., Rappaport, E. F., … Hakonarson, H. (2008). Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. New England Journal of Medicine, 358(24), 2585-2593.
Marques, A. C., & Ponting, C. P. (2014). Intergenic lncRNAs and the evolution of gene expression. Current Opinion in Genetics & Development, 27, 48-53.
Mattick, J. S., Amaral, P. P., Dinger, M. E., Mercer, T. R., & Mehler, M. F. (2009). RNA regulation of epigenetic processes. BioEssays, 31(1), 51-59.
Mattick, J. S., & Gagen, M. J. (2001). The evolution of controlled multitasked gene networks: The role of introns and other noncoding RNAs in the development of complex organisms. Molecular Biology and Evolution, 18(9), 1611-1630.
Mattick, J. S., & Rinn, J. L. (2015). Discovery and annotation of long noncoding RNAs. Nature Structural & Molecular Biology, 22(1), 5-7.
Meng, Q., Ren, M., Li, Y., & Song, X. (2016). LncRNA-RMRP acts as an oncogene in lung cancer. PLoS One, 11(12), e0164845.
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009). Long non-coding RNAs: Insights into functions. Nature Reviews Genetics, 10(3), 155-159.
Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., Ebus, M. E., Haneveld, F., Lakeman, A., Schild, L., Molenaar, P., Stroeken, P., van Noesel, M. M., Øra, I., Santo, E. E., … Versteeg, R. (2012). Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature, 483(7391), 589-593.
Monclair, T., Brodeur, G. M., Ambros, P. F., Brisse, H. J., Cecchetto, G., Holmes, K., Kaneko, M., London, W. B., Matthay, K. K., Nuchtern, J. G., von Schweinitz, D., Simon, T., Cohn, S. L., Pearson, A. D., & INRG Task Force. (2009). The international neuroblastoma risk group (INRG) staging system: An INRG task force report. Journal of Clinical Oncology, 27(2), 298-303.
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., Laureys, G., Speleman, F., Kim, C., Hou, C., Hakonarson, H., Torkamani, A., Schork, N. J., Brodeur, G. M., Tonini, G. P., … Maris, J. M. (2008). Identification of ALK as a major familial neuroblastoma predisposition gene. Nature, 455(7215), 930-935.
Pajtler, K. W., Mahlow, E., Odersky, A., Lindner, S., Stephan, H., Bendix, I., Eggert, A., Schramm, A., & Schulte, J. H. (2014). Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells. Oncotarget, 5(22), 11180-11192.
Pan, J., Zhang, D., Zhang, J., Qin, P., & Wang, J. (2019). LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases. Cancer Biology & Therapy, 20(5), 653-665.
Pandey, G. K., & Kanduri, C. (2015). Long noncoding RNAs and neuroblastoma. Oncotarget, 6(21), 18265-18275.
Pandey, G. K., Mitra, S., Subhash, S., Hertwig, F., Kanduri, M., Mishra, K., Fransson, S., Ganeshram, A., Mondal, T., Bandaru, S., Östensson, M., Akyürek, L. M., Abrahamsson, J., Pfeifer, S., Larsson, E., Shi, L., Peng, Z., Fischer, M., Martinsson, T., … Kanduri, C. (2014). The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell, 26(5), 722-737.
Panzitt, K., Tschernatsch, M. M. O., Guelly, C., Moustafa, T., Stradner, M., Strohmaier, H. M., Buck, C. R., Denk, H., Schroeder, R., Trauner, M., & Zatloukal, K. (2007). Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132(1), 330-342.
Park, J. R., Eggert, A., & Caron, H. (2008). Neuroblastoma: Biology, prognosis, and treatment. Pediatric Clinics of North America, 55(1), 97-120.
Pickard, M., Mourtada-Maarabouni, M., & Williams, G. (2013). Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1832(10), 1613-1623.
Pinto, N. R., Applebaum, M. A., Volchenboum, S. L., Matthay, K. K., London, W. B., Ambros, P. F., Nakagawara, A., Berthold, F., Schleiermacher, G., Park, J. R., Valteau-Couanet, D., Pearson, A. D. J., & Cohn, S. L. (2015). Advances in risk classification and treatment strategies for neuroblastoma. Journal of Clinical Oncology, 33(27), 3008-3017.
Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W. J., & Pandolfi, P. P. (2010). A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 465(7301), 1033-1038.
Pollard, K. S., Hubisz, M. J., Rosenbloom, K. R., & Siepel, A. (2010). Detection of nonneutral substitution rates on mammalian phylogenies. Genome Research, 20(1), 110-121.
Renganathan, A., Kresoja-Rakic, J., Echeverry, N., Ziltener, G., Vrugt, B., Opitz, I., Stahel, R. A., & Felley-Bosco, E. (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Molecular Cancer, 13(1), 119.
Russell, M. R., Penikis, A., Oldridge, D. A., Alvarez-Dominguez, J. R., McDaniel, L., Diamond, M., Padovan, O., Raman, P., Li, Y., Wei, J. S., Zhang, S., Gnanchandran, J., Seeger, R., Asgharzadeh, S., Khan, J., Diskin, S. J., Maris, J. M., & Cole, K. A. (2015). CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus. Cancer Research, 75(15), 3155-3166.
Sahu, D., Hsu, C. L., Lin, C. C., Yang, T. W., Hsu, W. M., Ho, S. Y., Juan, H. F., & Huang, H. C. (2016). Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma. Oncotarget, 7(36), 58022-58037.
Sati, S., Ghosh, S., Jain, V., Scaria, V., & Sengupta, S. (2012). Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci. Nucleic Acids Research, 40(20), 10018-10031.
Scaruffi, P., Stigliani, S., Moretti, S., Coco, S., de Vecchi, C., Valdora, F., Garaventa, A., Bonassi, S., & Tonini, G. P. (2009). Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer, 9(1), 441.
Schmidt, L. H., Spieker, T., Koschmieder, S., Humberg, J., Jungen, D., Bulk, E., Hascher, A., Wittmer, D., Marra, A., Hillejan, L., Wiebe, K., Berdel, W. E., Wiewrodt, R., & Muller-Tidow, C. (2011). The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. Journal of Thoracic Oncology, 6(12), 1984-1992.
Schulte, J. H., Schowe, B., Mestdagh, P., Kaderali, L., Kalaghatgi, P., Schlierf, S., Vermeulen, J., Brockmeyer, B., Pajtler, K., Thor, T., de Preter, K., Speleman, F., Morik, K., Eggert, A., Vandesompele, J., & Schramm, A. (2010). Accurate prediction of neuroblastoma outcome based on miRNA expression profiles. International Journal of Cancer, 127(10), 2374-2385.
Schwab, M. (1993). Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Seminars in Cancer Biology, 4(1), 13-18.
Shao, Y., Ye, M., Li, Q., Sun, W., Ye, G., Zhang, X., Yang, Y., Xiao, B., & Guo, J. (2016). LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer. Oncotarget, 7(25), 37812-37824.
Smith, C. M., & Steitz, J. A. (1998). Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Molecular and Cellular Biology, 18(12), 6897-6909.
Spitz, R., Hero, B., Ernestus, K., & Berthold, F. (2003). Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. Clinical Cancer Research, 9(1), 52-58.
Svoboda, M., Slyskova, J., Schneiderova, M., Makovicky, P., Bielik, L., Levy, M., Lipska, L., Hemmelova, B., Kala, Z., Protivankova, M., Vycital, O., Liska, V., Schwarzova, L., Vodickova, L., & Vodicka, P. (2014). HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis, 35(7), 1510-1515.
Taniue, K., Kurimoto, A., Sugimasa, H., Nasu, E., Takeda, Y., Iwasaki, K., Nagashima, T., Okada-Hatakeyama, M., Oyama, M., Kozuka-Hata, H., Hiyoshi, M., Kitayama, J., Negishi, L., Kawasaki, Y., & Akiyama, T. (2016). Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. Proceedings of the National Academy of Sciences, 113(5), 1273-1278.
Triche, T. (1986). Neuroblastoma-biology confronts nosology. Archives of Pathology & Laboratory Medicine, 110, 994-996.
Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., Blencowe, B. J., Prasanth, S. G., & Prasanth, K. V. (2010). The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell, 39(6), 925-938.
Tsai, M.-C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., Shi, Y., Segal, E., & Chang, H. Y. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329(5992), 689-693.
Ulitsky, I., & Bartel, D. P. (2013). lincRNAs: Genomics, evolution, and mechanisms. Cell, 154(1), 26-46.
Valentijn, L. J., Koster, J., Haneveld, F., Aissa, R. A., van Sluis, P., Broekmans, M. E. C., Molenaar, J. J., van Nes, J., & Versteeg, R. (2012). Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proceedings of the National Academy of Sciences, 109(47), 19190-19195.
Vance, K. W., Sansom, S. N., Lee, S., Chalei, V., Kong, L., Cooper, S. E., Oliver, P. L., & Ponting, C. P. (2014). The long non-coding RNA Paupar regulates the expression of both local and distal genes. The EMBO Journal, 33(4), 296-311.
Vermeulen, J., de Preter, K., Naranjo, A., Vercruysse, L., van Roy, N., Hellemans, J., Swerts, K., Bravo, S., Scaruffi, P., Tonini, G. P., de Bernardi, B., Noguera, R., Piqueras, M., Cañete, A., Castel, V., Janoueix-Lerosey, I., Delattre, O., Schleiermacher, G., Michon, J., … Vandesompele, J. (2009). Predicting outcomes for children with neuroblastoma using a multigene-expression signature: A retrospective SIOPEN/COG/GPOH study. The Lancet Oncology, 10(7), 663-671.
Wang, C., Liu, Z., Woo, C. W., Li, Z., Wang, L., Wei, J. S., Marquez, V. E., Bates, S. E., Jin, Q., Khan, J., Ge, K., & Thiele, C. J. (2012). EZH2 mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Research, 72(1), 315-324.
Wang, K. C., & Chang, H. Y. (2011). Molecular mechanisms of long noncoding RNAs. Molecular Cell, 43(6), 904-914.
Wang, L., Park, H. J., Dasari, S., Wang, S., Kocher, J. P., & Li, W. (2013). CPAT: Coding-potential assessment tool using an alignment-free logistic regression model. Nucleic Acids Research, 41(6), e74.
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014). Childhood and adolescent cancer statistics, 2014. CA: A Cancer Journal for Clinicians, 64(2), 83-103.
Watters, K. M., Bryan, K., Foley, N. H., Meehan, M., & Stallings, R. L. (2013). Expressional alterations in functional ultra-conserved non-coding rnas in response to all-trans retinoic acid-induced differentiation in neuroblastoma cells. BMC Cancer, 13(1), 184.
Wei, J. S., Johansson, P., Chen, Q. R., Song, Y. K., Durinck, S., Wen, X., Cheuk, A. T. C., Smith, M. A., Houghton, P., Morton, C., & Khan, J. (2009). microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies. Clinical Cancer Research, 15(17), 5560-5568.
Westermann, F., & Schwab, M. (2002). Genetic parameters of neuroblastomas. Cancer Letters, 184(2), 127-147.
Xu, Z.-Y., Yu, Q. M., du, Y. A., Yang, L. T., Dong, R. Z., Huang, L., Yu, P. F., & Cheng, X. D. (2013). Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. International Journal of Biological Sciences, 9(6), 587-597.
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., Smith, M., Anderson, B., Villablanca, J. G., Matthay, K. K., Shimada, H., Grupp, S. A., Seeger, R., Reynolds, C. P., Buxton, A., Reisfeld, R. A., Gillies, S. D., Cohn, S. L., Maris, J. M., … Children's Oncology Group. (2010). Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. New England Journal of Medicine, 363(14), 1324-1334.
Zhao, X., Li, D., Huang, D., Song, H., Mei, H., Fang, E., Wang, X., Yang, F., Zheng, L., Huang, K., & Tong, Q. (2018). Risk-associated long noncoding RNA FOXD3-AS1 inhibits neuroblastoma progression by repressing PARP1-mediated activation of CTCF. Molecular Therapy, 26(3), 755-773.
Zhao, X., Li, D., Pu, J., Mei, H., Yang, D., Xiang, X., Qu, H., Huang, K., Zheng, L., & Tong, Q. (2016). CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene, 35(27), 3565-3576.
فهرسة مساهمة: Keywords: biomarkers; lncRNA; neuroblastoma; prognosis
المشرفين على المادة: 0 (RNA, Long Noncoding)
0 (Biomarkers, Tumor)
تواريخ الأحداث: Date Created: 20230609 Date Completed: 20230814 Latest Revision: 20230820
رمز التحديث: 20230820
DOI: 10.1111/cbdd.14263
PMID: 37291742
قاعدة البيانات: MEDLINE
الوصف
تدمد:1747-0285
DOI:10.1111/cbdd.14263